Pub Date : 2024-03-07DOI: 10.1016/j.aopr.2024.03.001
Wei Wu , Lisha Yi , Kai Zhang , Zipei Chen , Caiping Shi , Chen Chen , Yilu Cai , Lidan Hu , Xiangjun Chen
Background
Refractive errors, particularly myopia, are the leading visual disorders worldwide, significantly affecting the quality of life (QOL) even after correction. This scoping review focuses on health-related quality of life (HRQOL) measurements for children and adolescents with refractive errors.
Main text
We explored generic and disease-specific HRQOL tools, examining their content, psychometric properties, and the impact of various interventions on QOL. Two English databases—PubMed, Embase, and one Chinese database, CNKI, were searched for relevant studies published from January 2001 to October 2023. Inclusion criteria encompassed studies using standardized instruments to assess the QOL of children aged 0–18 with refractive errors. The review compares prevalent HRQOL measurements, analyzes children's refractive error assessments, and discusses intervention effects on patient QOL.
Conclusions
The study underlines the necessity of developing disease-specific QOL instruments for very young children and serves as a practical guide for researchers in this field. The findings advocate for a targeted approach in HRQOL assessment among the pediatric population, identifying critical gaps in current methodologies.
背景屈光不正，尤其是近视，是全球主要的视觉疾病，即使在矫正后也会严重影响生活质量（QOL）。正文我们探讨了通用的和特定疾病的 HRQOL 工具，研究了它们的内容、心理测量学特性以及各种干预措施对 QOL 的影响。我们在两个英文数据库--PubMed 和 Embase，以及一个中文数据库--CNKI 中检索了 2001 年 1 月至 2023 年 10 月间发表的相关研究。纳入标准包括使用标准化工具评估 0-18 岁屈光不正儿童 QOL 的研究。该综述比较了普遍的 HRQOL 测量方法，分析了儿童屈光不正评估结果，并讨论了对患者 QOL 的干预效果。结论该研究强调了为年幼儿童开发特定疾病 QOL 工具的必要性，并为该领域的研究人员提供了实用指南。研究结果提倡在儿科人群中采用有针对性的方法进行 HRQOL 评估，并指出了当前方法中存在的关键差距。
{"title":"Health-related quality of life measurements in children and adolescents with refractive errors: A scoping review","authors":"Wei Wu , Lisha Yi , Kai Zhang , Zipei Chen , Caiping Shi , Chen Chen , Yilu Cai , Lidan Hu , Xiangjun Chen","doi":"10.1016/j.aopr.2024.03.001","DOIUrl":"10.1016/j.aopr.2024.03.001","url":null,"abstract":"<div><h3>Background</h3><p>Refractive errors, particularly myopia, are the leading visual disorders worldwide, significantly affecting the quality of life (QOL) even after correction. This scoping review focuses on health-related quality of life (HRQOL) measurements for children and adolescents with refractive errors.</p></div><div><h3>Main text</h3><p>We explored generic and disease-specific HRQOL tools, examining their content, psychometric properties, and the impact of various interventions on QOL. Two English databases—PubMed, Embase, and one Chinese database, CNKI, were searched for relevant studies published from January 2001 to October 2023. Inclusion criteria encompassed studies using standardized instruments to assess the QOL of children aged 0–18 with refractive errors. The review compares prevalent HRQOL measurements, analyzes children's refractive error assessments, and discusses intervention effects on patient QOL.</p></div><div><h3>Conclusions</h3><p>The study underlines the necessity of developing disease-specific QOL instruments for very young children and serves as a practical guide for researchers in this field. The findings advocate for a targeted approach in HRQOL assessment among the pediatric population, identifying critical gaps in current methodologies.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000192/pdfft?md5=1487260258181248186dbd591ed76281&pid=1-s2.0-S2667376224000192-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140269867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.aopr.2024.02.003
Sitong Ju , Alexander C. Rokohl , Yongwei Guo , Ke Yao , Wanlin Fan , Ludwig M. Heindl
Background
The periocular skin is neoplasms-prone to various benign and malignant. Periocular malignancies are more aggressive and challenging to cure and repair than those in other skin areas. In recent decades, immunotherapy has significantly advanced oncology, allowing the autoimmune system to target and destroy malignant cells. Skin malignancies, especially periocular tumors, are particularly sensitive to immunotherapy. This technique has dramatically impacted the successful treatment of challenging tumors.
Main text
Extraocular cancers, including eyelid (basal cell carcinoma, squamous cell carcinoma, melanoma, merkel cell carcinoma), conjunctival tumors (conjunctival melanoma, ocular surface squamous neoplasia) and other rare tumors, are unique and challenging clinical situations. Several genetic alterations associated with the pathogenesis of these diseases have been identified, and molecular mechanism are essential for the development of the immunotherapy agents, such as Hedgehog pathway inhibitors (vismodegib and sonidegib) for basal cell carcinoma, BRAF/MEK inhibitors (vemurafenib, dabrafenib, and encorafenib) for melanoma, and immune checkpoint inhibitors (Avelumab, pembrolizumab) for Merkel cell carcinoma.
Conclusions
The optimal treatment for periocular skin cancer depends on the type and size of the tumor and whether it involves orbital and adnexal structures. Adjuvant and neoadjuvant therapy with chemotherapy-targeted therapies and immune checkpoint inhibitors should be considered based on tumor type, tumor molecular profile, expected response rate, and candidacy for systemic treatment.
{"title":"Personalized treatment concepts in extraocular cancer","authors":"Sitong Ju , Alexander C. Rokohl , Yongwei Guo , Ke Yao , Wanlin Fan , Ludwig M. Heindl","doi":"10.1016/j.aopr.2024.02.003","DOIUrl":"10.1016/j.aopr.2024.02.003","url":null,"abstract":"<div><h3>Background</h3><p>The periocular skin is neoplasms-prone to various benign and malignant. Periocular malignancies are more aggressive and challenging to cure and repair than those in other skin areas. In recent decades, immunotherapy has significantly advanced oncology, allowing the autoimmune system to target and destroy malignant cells. Skin malignancies, especially periocular tumors, are particularly sensitive to immunotherapy. This technique has dramatically impacted the successful treatment of challenging tumors.</p></div><div><h3>Main text</h3><p>Extraocular cancers, including eyelid (basal cell carcinoma, squamous cell carcinoma, melanoma, merkel cell carcinoma), conjunctival tumors (conjunctival melanoma, ocular surface squamous neoplasia) and other rare tumors, are unique and challenging clinical situations. Several genetic alterations associated with the pathogenesis of these diseases have been identified, and molecular mechanism are essential for the development of the immunotherapy agents, such as Hedgehog pathway inhibitors (vismodegib and sonidegib) for basal cell carcinoma, BRAF/MEK inhibitors (vemurafenib, dabrafenib, and encorafenib) for melanoma, and immune checkpoint inhibitors (Avelumab, pembrolizumab) for Merkel cell carcinoma.</p></div><div><h3>Conclusions</h3><p>The optimal treatment for periocular skin cancer depends on the type and size of the tumor and whether it involves orbital and adnexal structures. Adjuvant and neoadjuvant therapy with chemotherapy-targeted therapies and immune checkpoint inhibitors should be considered based on tumor type, tumor molecular profile, expected response rate, and candidacy for systemic treatment.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000118/pdfft?md5=edb4a670137034508a3c47340bef9273&pid=1-s2.0-S2667376224000118-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140082944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-28DOI: 10.1016/j.aopr.2024.02.001
Yifei Niu , Junfeng Ji , Ke Yao , Qiuli Fu
Background
Degenerate eye disorders, such as glaucoma, cataracts and age-related macular degeneration (AMD), are prevalent causes of blindness and visual impairment worldwide. Other eye disorders, including limbal stem cell deficiency (LSCD), dry eye diseases (DED), and retinitis pigmentosa (RP), result in symptoms such as ocular discomfort and impaired visual function, significantly impacting quality of life. Traditional therapies are limited, primarily focus on delaying disease progression, while emerging stem cell therapy directly targets ocular tissues, aiming to restore ocular function by reconstructing ocular tissue.
Main text
The utilization of stem cells for the treatment of diverse degenerative ocular diseases is becoming increasingly significant, owing to the regenerative and malleable properties of stem cells and their functional cells. Currently, stem cell therapy for ophthalmopathy involves various cell types, such as embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and retinal progenitor cells (RPCs). In the current article, we will review the current progress regarding the utilization of stem cells for the regeneration of ocular tissue covering key eye tissues from the cornea to the retina. These therapies aim to address the loss of functional cells, restore damaged ocular tissue and or in a paracrine-mediated manner. We also provide an overview of the ocular disorders that stem cell therapy is targeting, as well as the difficulties and opportunities in this field.
Conclusions
Stem cells can not only promote tissue regeneration but also release exosomes to mitigate inflammation and provide neuroprotection, making stem cell therapy emerge as a promising approach for treating a wide range of eye disorders through multiple mechanisms.
{"title":"Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges","authors":"Yifei Niu , Junfeng Ji , Ke Yao , Qiuli Fu","doi":"10.1016/j.aopr.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.aopr.2024.02.001","url":null,"abstract":"<div><h3>Background</h3><p>Degenerate eye disorders, such as glaucoma, cataracts and age-related macular degeneration (AMD), are prevalent causes of blindness and visual impairment worldwide. Other eye disorders, including limbal stem cell deficiency (LSCD), dry eye diseases (DED), and retinitis pigmentosa (RP), result in symptoms such as ocular discomfort and impaired visual function, significantly impacting quality of life. Traditional therapies are limited, primarily focus on delaying disease progression, while emerging stem cell therapy directly targets ocular tissues, aiming to restore ocular function by reconstructing ocular tissue.</p></div><div><h3>Main text</h3><p>The utilization of stem cells for the treatment of diverse degenerative ocular diseases is becoming increasingly significant, owing to the regenerative and malleable properties of stem cells and their functional cells. Currently, stem cell therapy for ophthalmopathy involves various cell types, such as embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and retinal progenitor cells (RPCs). In the current article, we will review the current progress regarding the utilization of stem cells for the regeneration of ocular tissue covering key eye tissues from the cornea to the retina. These therapies aim to address the loss of functional cells, restore damaged ocular tissue and or in a paracrine-mediated manner. We also provide an overview of the ocular disorders that stem cell therapy is targeting, as well as the difficulties and opportunities in this field.</p></div><div><h3>Conclusions</h3><p>Stem cells can not only promote tissue regeneration but also release exosomes to mitigate inflammation and provide neuroprotection, making stem cell therapy emerge as a promising approach for treating a wide range of eye disorders through multiple mechanisms.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266737622400009X/pdfft?md5=05a06b3fd055e75a8b44dbdd244049e6&pid=1-s2.0-S266737622400009X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-28DOI: 10.1016/j.aopr.2024.02.002
Nina Asrini Noor, Johan Hutauruk, Tjahjono D. Gondhowiardjo
{"title":"The use of lens anterior capsule disc for corneal endothelium protection during femtosecond laser-assisted cataract surgery in eyes with low endothelial cell density","authors":"Nina Asrini Noor, Johan Hutauruk, Tjahjono D. Gondhowiardjo","doi":"10.1016/j.aopr.2024.02.002","DOIUrl":"https://doi.org/10.1016/j.aopr.2024.02.002","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000106/pdfft?md5=cf04f59f1f87a91803321fe676a2309a&pid=1-s2.0-S2667376224000106-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140332463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-10DOI: 10.1016/j.aopr.2024.01.006
Lin Lin , Yirui Zhu , Kelan Yuan, Yujie Mou, Hanhe Zhao, Yayin Wu, Xiuming Jin
{"title":"Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye","authors":"Lin Lin , Yirui Zhu , Kelan Yuan, Yujie Mou, Hanhe Zhao, Yayin Wu, Xiuming Jin","doi":"10.1016/j.aopr.2024.01.006","DOIUrl":"10.1016/j.aopr.2024.01.006","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000064/pdfft?md5=789942a866e56ed7a429a4450875c3fb&pid=1-s2.0-S2667376224000064-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139824158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01DOI: 10.1016/j.aopr.2024.01.007
Linyan Wang , Davin C. Ashraf , Michael Deiner , Oluwatobi O. Idowu , Seanna R. Grob , Bryan J. Winn , M Reza Vagefi , Robert C. Kersten
Objective
To investigate whether functional upper eyelid malposition is associated with unrecognized deficits in automated perimetry among glaucoma patients by examining patients undergoing eyelid surgery who had not been identified as requiring eyelid taping during glaucoma field testing.
Methods
In this retrospective pre-post study, an automated database search followed by manual chart review was used to identify eligible patients from January 2012 to March 2020. Included patients had reliable visual field testing within two years before and after functional upper blepharoplasty or ptosis repair and no comorbid ocular diagnoses. As part of routine practice, glaucoma visual field technicians taped patients with pupil-obstructing eyelid malposition; taped examinations were excluded from analysis. Clinical and demographic characteristics, mean deviation, and pattern standard deviation were evaluated within a two year period before and after eyelid surgery.
Results
The final analysis included 60 eyes of 38 patients. Change in visual field parameters after eyelid surgery did not reach statistical significance in crude or adjusted analyses. Among patients with ptosis, the margin reflex distance-1 was not associated with change in mean deviation after surgery (Pearson R2 = 0.0061; P = 0.700). Five of 17 eyes excluded from analysis due to unreliable pre-operative visual fields demonstrated substantial improvement after surgery.
Conclusions
Functional upper eyelid malposition does not appear to cause spurious visual field abnormalities among glaucoma patients with reliable visual fields who were determined not to require eyelid taping at the time of their visual fields. Unreliable visual fields could be a sign of eyelid interference in this population.
{"title":"Evaluating for unrecognized deficits in perimetry associated with functional upper eyelid malposition","authors":"Linyan Wang , Davin C. Ashraf , Michael Deiner , Oluwatobi O. Idowu , Seanna R. Grob , Bryan J. Winn , M Reza Vagefi , Robert C. Kersten","doi":"10.1016/j.aopr.2024.01.007","DOIUrl":"10.1016/j.aopr.2024.01.007","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate whether functional upper eyelid malposition is associated with unrecognized deficits in automated perimetry among glaucoma patients by examining patients undergoing eyelid surgery who had not been identified as requiring eyelid taping during glaucoma field testing.</p></div><div><h3>Methods</h3><p>In this retrospective pre-post study, an automated database search followed by manual chart review was used to identify eligible patients from January 2012 to March 2020. Included patients had reliable visual field testing within two years before and after functional upper blepharoplasty or ptosis repair and no comorbid ocular diagnoses. As part of routine practice, glaucoma visual field technicians taped patients with pupil-obstructing eyelid malposition; taped examinations were excluded from analysis. Clinical and demographic characteristics, mean deviation, and pattern standard deviation were evaluated within a two year period before and after eyelid surgery.</p></div><div><h3>Results</h3><p>The final analysis included 60 eyes of 38 patients. Change in visual field parameters after eyelid surgery did not reach statistical significance in crude or adjusted analyses. Among patients with ptosis, the margin reflex distance-1 was not associated with change in mean deviation after surgery (Pearson R<sup>2</sup> = 0.0061; <em>P</em> = 0.700). Five of 17 eyes excluded from analysis due to unreliable pre-operative visual fields demonstrated substantial improvement after surgery.</p></div><div><h3>Conclusions</h3><p>Functional upper eyelid malposition does not appear to cause spurious visual field abnormalities among glaucoma patients with reliable visual fields who were determined not to require eyelid taping at the time of their visual fields. Unreliable visual fields could be a sign of eyelid interference in this population.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000076/pdfft?md5=7d65e214918326babd8fa3dfa141f722&pid=1-s2.0-S2667376224000076-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139815843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01DOI: 10.1016/j.aopr.2024.01.006
Lin Lin, Yirui Zhu, Kelan Yuan, Yujie Mou, Hanhe Zhao, Yaying Wu, Xiuming Jin
{"title":"Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye","authors":"Lin Lin, Yirui Zhu, Kelan Yuan, Yujie Mou, Hanhe Zhao, Yaying Wu, Xiuming Jin","doi":"10.1016/j.aopr.2024.01.006","DOIUrl":"https://doi.org/10.1016/j.aopr.2024.01.006","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139883915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01DOI: 10.1016/j.aopr.2024.01.001
Lipu Cui, Chenhao Yang, Haidong Zou
{"title":"A two-year longitudinal observational study of the peripapillary microvasculature in pediatric type 1 diabetes mellitus patients without visual impairment or diabetic retinopathy","authors":"Lipu Cui, Chenhao Yang, Haidong Zou","doi":"10.1016/j.aopr.2024.01.001","DOIUrl":"https://doi.org/10.1016/j.aopr.2024.01.001","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000015/pdfft?md5=a4001c50e3181f3eeb005e686e4b871e&pid=1-s2.0-S2667376224000015-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-01DOI: 10.1016/S2667-3762(24)00015-5
{"title":"TOC","authors":"","doi":"10.1016/S2667-3762(24)00015-5","DOIUrl":"https://doi.org/10.1016/S2667-3762(24)00015-5","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000155/pdfft?md5=fb30c91080e2dbba6039c1f7cd1f093b&pid=1-s2.0-S2667376224000155-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140163776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response to letter to the editor regarding \"Is relying on RNFL specific enough to identify any changes in the CNS?\"","authors":"Hanfei Wu , Haishuang Lin , Mengting Ruan, Huanjie Fang, Nannan Dong, Tiewei Wang, Feifei Yu, Jiawei Zhao","doi":"10.1016/j.aopr.2024.01.003","DOIUrl":"10.1016/j.aopr.2024.01.003","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000039/pdfft?md5=872602d7517fc9cdf6766598481ffda6&pid=1-s2.0-S2667376224000039-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139817368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号